
MASI — Masimo Corporation
NASDAQ · Healthcare · Medical Devices
Masimo Corporation (MASI) is a medical devices company listed on NASDAQ. It is led by Catherine M. Szyman, based in 52 Discovery, Irvine, CA, United States, 92618, with about 3,600 employees. Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Latest reported MASI revenue for 2025-09-27 was $371.5M. Net income was -$100.4M. Revenue was up 0.2% from 2025-06-28 to 2025-09-27. MASI currently screens at market cap $9.02B.
Use this MASI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MASI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MASI SEC filings page. Lician reads the product cache first so this HTML stays unique to Masimo Corporation even when a live quote feed is slow.
About Masimo Corporation
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
MASI Key Statistics
Market Cap
$9.02B
EPS
-$5.72
Revenue
$2.09B
Net Income
-$304.90M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+2.3%
Profit Margin
-14.6%
Employees
3,600
MASI Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $2.09B | $2.05B | $2.04B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$304.90M | $81.50M | $143.50M |
| EPS (Diluted) | -$5.72 | $1.51 | $2.60 |
Total Assets
$2.63B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$177.60M
Operating Cash Flow
$196.40M
Free Cash Flow
$0.00
Masimo Corporation Company Information
- CEO & Director
- Catherine M. Szyman
- Headquarters
- 52 Discovery, Irvine, CA, United States, 92618
- Website
- www.masimo.com
- Phone
- 949 297 7000
- IPO / Founded
- 2007-08-08
- Sector
- Healthcare
- Industry
- Medical Devices